Finally, the in vivo inhibition of miR-138-5p was shown to reduce the development of severe experimental PAH by regulating the expression of MCU1 (mitochondrial Ca2+ uniportor 1) and CREB (cAMP response element binding) [17]. Here, CREB1 is linked to pulmonary arterial hypertension.